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Summary
Objective: Current osteoarthritis (OA) histopathology assessment methods have difﬁculties in their utility for early disease, as well as their
reproducibility and validity. Our objective was to devise a more useful method to assess OA histopathology that would have wide application
for clinical and experimental OA assessment and would become recognized as the standard method.
Design: An OARSI Working Group deliberated on principles, standards and features for an OA cartilage pathology assessment system. Using
current knowledge of the pathophysiology of OA morphologic features, a proposed system was presented at OARSI 2000. Subsequently, this
was widely circulated for comments amongst experts in OA pathology.
Results: An OA cartilage pathology assessment system based on six grades, which reﬂect depth of the lesion and four stages reﬂecting extent
of OA over the joint surface was developed.
Conclusions: The OARSI cartilage OA histopathology grading system appears consistent and simple to apply. Further studies are required to
conﬁrm the system’s utility.
ª 2005 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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A major obstacle to understanding osteoarthritis (OA)
natural history and its modiﬁcations by therapy has been
1Support: Osteoarthritis Research Society International.
2Presented in part at OARSI 2000, Barcelona, Spain, October
4e7, 2000.
*Address correspondence and reprint requests to: Dr Kenneth
P. H. Pritzker, Pathology and Laboratory Medicine, Mount Sinai
Hospital, 600 University Avenue, Toronto, Ontario, Canada, M5G
1X5. Tel: 1-416-586-4453; Fax: 1-416-586-8589; E-mail:
kpritzker@mtsinai.on.ca
Received 3 May 2004; revision accepted 14 July 2005.1lack of consensus concerning the order and role of cartilage
pathologic features characteristic for OA biologic activity
and progression. Further, common histopathologic assess-
ment methods (Grade) under both clinical and experimental
conditions reﬂect poorly mild (or early) phases of disease,
have wide interobserver variation and are very non-linear
over the range from mild to advanced disease1e3. Recent
biologic advances have enabled classiﬁcation of OA
cartilage pathology features into those of activity and
progression and have facilitated functional correlation of
osteoarthritic cartilage morphologic changes4.
Most current methods for OA histopathologic assessment
are based on macroscopic assessment grading system3
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chemical Grading System (HHGS) developed in 1971 by
Mankin et al.7.
Collins, in his pioneering work, had as his aim to identify
macroscopic OA pathology and to classify the observations
into lesser (earlier) changes and more advanced OA5,6,8.
The Collins system was based on observation of knee
tissues, usually distal femur removed at incidental surgery
or at autopsy. Collins graded OA severity as Grades IeIV
using extensive qualitative descriptions of cartilage surface
texture, lesion size and bony changes. Of this system,
Collins5, wrote ‘‘This grading system is, of course, arbitrary
and in no way represents ﬁxed stages in the progress of the
disease’’. The ﬁrst step towards an osteoarthritic cartilage
grading system based on biologic disease mechanisms
was the work of Collins and McElligott8 who assessed
patellas removed at autopsy from 34 patients. They studied
35SO4 uptake by chondrocytes and correlated these
ﬁndings to histologic changes of OA. Chondrocytes in
osteoarthritic cartilage showed increased 35SO4 uptake,
and osteoarthritic cartilage from higher Collins grades
(Grades III and IV) showed more 35SO4 uptake than
chondrocytes from lesser lesions (Grades I and II). This
work demonstrated that hyaline cartilage chondrocytes in
OA were hyperactive, not inert or effete. These studies,
showing that osteoarthritic chondrocytes were very meta-
bolically active, changed the concept of OA from a mechan-
ical condition of cartilage ‘‘wear and tear’’ to a disease of
biologic reaction.
Mankin et al.7, in an equally pioneeringwork, developed an
OA pathology grading system using femoral heads removed
at arthroplastic surgery. The objectives of their study were to
provide a histopathologic correlation with cartilage biochem-
ical changes associated with OA progression. Mankin’s
histopathology grading system was based on microscopic
evaluation of decalciﬁed sections of surgically removed
osteoarthritic femoral heads stained by Safranin O with Light
Green counterstain. This systemuseda 14point score based
on a composite of cellular changes, histochemical presence
of Safranin O matrix staining and architectural changes
(erosion, vessel penetration through tidemark). This system
is known eponymously as the Mankin System or, more
recently, as the HHGS1,2. In the following years, this method
was adapted andmodiﬁed by most investigators. The HHGS
has been applied to study OA spontaneously arising in
humans, non-human primates and other animals, as well as
to investigations of experimental OA models, generated by
surgical lesions to induce instability or by other means9.
Both these grading systems were based on study of
specimens with very advanced OA. It is not surprising that
these grading systems were not linear for mild or earlier
phases of the disease typical of the pathology observed in
many OA model systems.
The reproducibility and the validity of the HHGS for
osteoarthritic cartilage has been questioned formally1,2.
In common with the trend to standardize the clinical,
radiologic and arthroscopic assessment of OA10,11, there
are growing needs to standardize the assessment of OA
histopathology. To address this need, in 1998 OARSI
established an OA Working Group to devise a standard OA
grading system based on current pathophysiologic knowl-
edge. It was recognized at the outset that human OA affects
all joint tissues with subchondral bone having a prominent
role in some OA subsets, as well as some experi-
mental models12. For practical reasons, it was decided to
conﬁne the grading system to one target tissue, articular
cartilage.First, the Working Group established a set of target
principles to guide the development of the grading system.
Second, it was agreed that the grading system should be
designed for broad but deﬁned applications in OA
assessment. Third, the Working Group recognized the
desirability to standardize conditions under which OA
cartilage pathology is assessed. The principles, applica-
tions and proposed standards for the grading system are
outlined below.
PRINCIPLES
The ﬁve principles for an ideal cartilage histopathology
system are: simplicity, utility, scalability, extendability and
comparability (Table I).
1. SimplicitydThe system should be simple and re-
producible. Therefore, the system should be able to
be applied easily by investigators with varying levels of
histopathology experience. At the very least, the
system should be superior to the HHGS or other OA
histopathology systems in current use, particularly in
assessment of early disease.
2. UtilitydThe system should be equally useful for
assessment of both clinical OA and experimental OA
models. While assessing morphologic changes, the
grading system should reﬂect biochemical and molec-
ular indicators of OA progression. The grading system
should be applicable with conventional histologic
preparations and stains.
3. ScalabilitydThe system should be scalable such that
the cartilage macroscopic appearance can be corre-
lated with the cartilage histopathology. Further, it
would be desirable to have the system scalable such
that the cartilage histopathology could be related
linearly to morphologic appearances seen on diagnos-
tic imaging and/or arthroscopy.
4. ExtendabilitydThe grading system design should be
capable of being applied successfully by an observer’s
qualitative observation of microscopic slides. However,
some research applications may beneﬁt from more
detailed grading/staging or by morphometric analysis
of the osteoarthritic features. Ideally, the system
should be capable of accommodating the needs of
most observers and, as well, be extendable to the few
advanced applications that require more morphologic
detail and/or morphometry.
5. ComparabilitydThe OA histopathology grading sys-
tem should be capable of being harmonized eventually
with histological assessment systems for other cartilage
Table I
OA cartilage histopathology assessmentdprinciples
Principles
1 Simplicity Simple, reproducible
2 Utility Useful for both clinical and
experimental OA
3 Scalability Direct extension from macroscopic
assessment to microscopic
histopathology
4 Extendability Extendable to more detailed grading/
staging or to morphometric
methodology
5 Comparability Comparable to pathology grading/
staging systems for other cartilage
disorders and to pathology grading
systems for other diseases
15Osteoarthritis and Cartilage Vol. 14, No. 1disorders or, at least, those assessment systems
associated with cartilage repair13,14.
APPLICATIONS
Applications for the OARSI osteoarthritis pathology as-
sessment system include distinguishing OA subsets, de-
ﬁning endpoints for clinical trials, evaluating newOA features
or biomarkers and evaluating animal models of OA.
1. Distinguishing OA subsetsdLong-standing historical
controversy surrounds the nomenclature of OA itself
(OA vs osteoarthrosis) and whether OA is primarily
a ‘‘degenerative’’ joint disease15e23. Similarly, the
spectrum or range of disease encompassed by the
term OA varies widely21. Historically, this variation has
been dependent both on medical discipline (orthopae-
dic surgeons, rheumatologists, pathologists) and on
geography, Europe (narrow deﬁnitions), North America
(broader deﬁnitions). Currently, OA is considered
a group of joint diseases characterized within articular
cartilage, in part, by simultaneous presence of cartilage
matrix degradation and regeneration/repair, as well as
chondrocyte death, chondrocyte replication and pro-
liferation4. OA may have several subsets, some of
which have cartilage as a primary lesion, others bone,
others soft tissue laxity or still others, a combination of
target tissues. Whatever the subsets, these forms of
OA, in their later stages, come to resemble each other
closely. A standard histopathology assessment system
that could identify early OA may well identify groups
which have differential features in either lesion location
or OA progression that permits subset identiﬁcation.
2. Defining clinical trial endpointsdA major issue in OA
clinical trials is the need to deﬁne endpoint criteria for
disease progression or modiﬁcation of progression by
therapy. Although all tissues of the joint are involved in
OA, the weight bearing cartilage surface is the critical
tissue affected. Whether the endpoint is viewed by
imaging techniques or, as has been done in a few
trials, by clinical biopsies, a standard histopathologic
assessment system for OA cartilage pathology is
required for clinical trial endpoints.
3. Evaluating new OA features or disease markers
characteristic of OAdAs the tissue composition of
cartilage becomes better known, there are many
different kinds of molecules which undergo change in
quality or quantity in OA. These may be directly
observed as a histopathologic feature or may be
present in synovial ﬂuid, blood or urine as surrogate
biomarkers. The need exists to deﬁne a standard
histologic system by which candidate surrogate bio-
markers of OA progression can be evaluated.
4. Evaluating animal models of OAdHistopathologic
assessment systems have been used extensively to
evaluate animal models of OA. Unfortunately, because
of the varied assessment systems employed, many of
these papers are very difﬁcult to compare to each other.
STANDARDIZATION OF OA CARTILAGE PATHOLOGY
ASSESSMENT
Prerequisites for grading and staging of OA cartilage
histopathology include both standardization of the assessmentsystem itself and, also, the conditions under which the
histopathology is assessed. These latter conditions include:
1. Standard definitions of OA cartilage histopathology
featuresdThe nomenclature of OA histopathology
features has evolved historically over the past 200
years with contributions by investigators in several
languages, principally Latin, Greek, German, French
and English. In the assessment system presented
here, an attempt has been made to use terms in
current, common use and to use the terms within
a precise and narrow deﬁnition. The deﬁnitions for
cartilage histology features and their modiﬁcation in
OA used in this paper are tabulated in the glossary,
Appendix A.
2. Standard exclusion criteria of other forms of arthri-
tisdWhile it is recognized that the features of OA are
different from those of inﬂammatory arthritis, there is
considerable overlap of primary OA histopathology
features with those of other forms of arthritis, which
have separate etiology and pathogenesis. This may be
particularly true in latter phases of the diseases where
different forms of arthritis may share some morpho-
logic features. In the absence of agreed exclusionary
criteria, the system should be applied principally to
primary OA and experimental OA. If the system is to
be used to assess OA features in other forms of
arthritis, this should be clearly speciﬁed.
3. Standard sampling for each joint and each joint
compartment (standard topology)dWhile sampling of
each joint at a standard anatomical plane may be
ideal, as yet there is no consensus on optimal
sampling planes. Indeed, different sample planes
may be required for different studies, depending on
the purpose, e.g., correlation with magnetic resonance
imaging; correlation with arthroscopy. While standard
topology may be ideal, in each study it is critically
important that the anatomical sampling plane be
deﬁned and described with precision, and that
samples with consistent speciﬁcations are taken
throughout the study. As lesions vary in location, it is
not useful to sample blocks in a precise anatomical
plane irrespective of lesion location. Rather, the lesion
should be sampled where the plane of the block
transverses the lesion to the greatest extent. Where
the lesion is very small, the sections should be cut into
the block until the maximal extent of the lesion is
reached. For small animals such as mice sections at
successive, different deeper levels may be required to
obtain appropriate phase to score OA optimally. For
assessment of human joints, there are particular
challenges. Ideally, there should be one sample block
which extends from one joint margin to the other
through the maximal extent of OA. This can be
accomplished at autopsy and with standard surgical
excisions of femoral head and knee joint tissues. As
these blocks may be large, special embedding
techniques may be required. However, as minimally
invasive surgery becomes more widely deployed,
smaller, more fragmented samples will likely result.
In these situations, display of the fragments in original
anatomical relationships will be necessary to obtain
the appropriate samples for staging and scoring.
Regarding directed cartilage biopsies which may be
indicated to assess disease modifying therapies,
a valid grading assessment can be made provided
16 K. P. H. Pritzker et al.: Osteoarthritis cartilage histopathologythat the biopsy is directed macroscopically to the most
advanced portion of the arthritic lesion. Staging and
scoring would not be possible in these circumstances,
unless staging was based on ancillary criteria, such as
arthroscopy and imaging.
4. Standard histologic preparation and staining of stan-
dard sectionsdAs tissues shrink differentially in differ-
ent ﬁxatives and as histologic technique is important to
reduce staining variation, it is important, at least within
each study, to deﬁne and describe the precise
conditions for histologic preparation24,25. The histologic
preparation technology, currently used at Mount Sinai
Hospital, Toronto, Canada, is presented in Appendix B.
While standard disease exclusion criteria, standard sam-
pling and standard histology preparation are all needed,
consensus on these standards is not yet available.
The tissues should be processed and stained according
to a standard protocol such as in Appendix B.
The OARSI osteoarthritis cartilage
histopathology assessment system
A draft OA histopathology assessment system incorpo-
rating the principles and design for the applications above
was presented to OARSI in October 200026. The system
follows an analogy of the concept widely used in cancer
pathology assessment. Increasing grade indicates a more
biologically aggressive disease; increasing stage indicates
greater disease extent. For OA, lesion depth into cartilage
area represents more severe arthritis; lesion extent over
cartilage surface represents extent of disease. Subsequently,
through feedback from the OARSI Working Group and other
interested members of the OA community, the cartilage
histopathology assessment system was reﬁned as de-
scribed below.
The OARSI Osteoarthritis Cartilage Histopathology
Assessment System is based on histologic features of OA
progression. Prior OA diagnosis and recognition of OA
activity within cartilage, such as chondrocyte clustering, is
assumed. All the grades and stages assume that the tissue
reaction observed has microscopic features characteristic
of OA activity4. The system employs analysis of a standard
block/section assessment by grade, stage of arthritis with
subsequent calculation of an arthritis score.
STANDARD HISTOLOGICAL BLOCK/SECTION FOR GRADE
AND STAGE ASSESSMENT METHODOLOGY
Each standard block/section for grade/stage assessment
is conﬁned to one articular surface and subjacent tissues
from one joint compartment, e.g., medial femoral condyle.
The section must extend horizontally from one edge of the
joint to the other and in depth from the articular surface
to below the articular bone plate. For small animals such
as mice, multiple sections of the block at deﬁned
different levels may be required to assess OA score
appropriately.
Microscopic sections are assessed at low power magni-
ﬁcation. The OARSI template to assess histopathology
grade (Table II and Figs. 1 and 2) can be used as a guide to
identify features and a reference scale marker line (on
microscope stage or eyepiece) can be used to estimate the
extent of OA. More elaborate morphometric methods for
staging can be used if more precision is required.Grade, stage and score
Grade is deﬁned as OA depth progression into cartilage.
Grade is an index of the severity or biologic progression of
the osteoarthritic process. This assumes that OA involve-
ment of deeper cartilage is a more advanced disease and
a good indicator of progressive disease. Grade is assessed
by noting the most advanced grade present within the
cartilage, irrespective of its horizontal extent. Stage is
deﬁned as the horizontal extent of cartilage involvement
within one side of a joint compartment irrespective of the
underlying grade. Score is deﬁned as assessment of
combined OA grade and OA stage. Therefore, score
represents a combined assessment of OA severity and
extent.
Table II
A carti lage histopathology grade assessmentdgrading
methodology
Grade (key feature) Associated criteria (tissue reaction)
Grade 0: surface
intact, cartilage
morphology intact
Matrix: normal architecture
Cells: intact, appropriate orientation
Grade 1: surface
intact
Matrix: superﬁcial zone intact, oedema
and/or superﬁcial ﬁbrillation (abrasion),
focal superﬁcial matrix condensation
Cells: death, proliferation (clusters),
hypertrophy, superﬁcial zone
Reaction must be more than superﬁcial
ﬁbrillation only
Grade 2: surface
discontinuity
As above
CMatrix discontinuity at superﬁcial
zone (deep ﬁbrillation)
GCationic stain matrix depletion
(Safranin O or Toluidine Blue) upper
1/3 of cartilage
GFocal perichondronal increased stain
(mid zone)
GDisorientation of chondron columns
Cells: death, proliferation (clusters),
hypertrophy
Grade 3: vertical
ﬁssures (clefts)
As above
Matrix vertical ﬁssures into mid zone,
branched ﬁssures
GCationic stain depletion (Safranin O or
Toluidine Blue) into lower 2/3 of cartilage
(deep zone)
GNew collagen formation (polarized light
microscopy, Picro Sirius Red stain)
Cells: death, regeneration (clusters),
hypertrophy, cartilage domains adjacent
to ﬁssures
Grade 4: erosion Cartilage matrix loss: delamination of
superﬁcial layer, mid layer cyst formation
Excavation: matrix loss superﬁcial layer
and mid zone
Grade 5: denudation Surface: sclerotic bone or reparative
tissue including ﬁbrocartilage within
denuded surface. Microfracture with
repair limited to bone surface
Grade 6: deformation Bone remodelling (more than osteophyte
formation only). Includes: microfracture
with ﬁbrocartilaginous and osseous
repair extending above the previous
surface
II. GradeZ depth progression into cartilage.
17Osteoarthritis and Cartilage Vol. 14, No. 1Fig. 1. (A & B) Normal articular cartilage: histologic features, grade 0. The cartilage surface is smooth. The matrix and chondrocytes are
organized into superﬁcial, mid and deep zones. (B) Safranin O stain, original magniﬁcation !5.OA grade. A key concept underlying the grading system
proposed is that whatever the biologic mechanisms, the
earliest cartilage changes in OA are observed near the
cartilage surface. As OA becomes more severe, increas-
ingly deeper cartilage becomes involved. Ultimately, the
cartilage becomes eroded completely and the subjacent
bone becomes the articular surface. The key features of
each OA grade are described in Table II and shown
graphically in Figs. 1 and 2.
Recommended OA grading method. With normal cartilage
as grade 0, OA severity is divided into six grades. Grades
1e4 involve articular cartilage changes only, whereas
grades 5 and 6 involve subchondral bone as well. The
morphologic features of the six grades are as follows:
Grade 0dGrade 0 is hyaline articular cartilage un-
involved with OA. In grade 0 (Fig. 1), the cartilage surface
is smooth. The matrix and associated chondrocytes are
organized in three appropriately oriented, well ordered
zones. No enlargement/distortion of chondrons and no
proliferative changes of chondrocytes are observed.
Grade 1dBy deﬁnition, grade 1 is the threshold for OA in
cartilage. Grade 1 OA is characterized by retention of the
articular surface layer. However, mild abrasion, termed
‘‘superﬁcial ﬁbrillation’’, characterized by microscopic
cracks into the superﬁcial zone, may be present. As this
type of ﬁbrillation is known to be directly mechanically
induced without biologic reaction27, this criterion alone is
insufﬁcient for OA. Other histology features in grade 1 OA
include focal or generalized cartilage matrix swelling
(oedema), which in extreme form, leads to cartilage
hypertrophy. Cartilage oedema may be reﬂected by matrix
changes such as focal rarefaction and condensation of
collagen ﬁbres in the superﬁcial zone or upper mid zone or
variable matrix cationic staining (Safranin O or Toluidine
Blue). Proliferation of chondrocytes in the superﬁcial zone,
characterized by chondrocyte clusters and/or disorientation
of chondrocytes, may be seen. Chondrocyte death is
identiﬁed by absence of chondrocytes within the chondron
or, more speciﬁcally, by presence of chondrocytes with
a cell membrane ‘‘ghost’’ and with nucleus lackingbasophilic staining. Apoptosis can be inferred by observing
fragmentation of chondrocyte nuclei. Chondrocyte hyper-
trophy can be recognized by the relative increase of
chondrocyte cytoplasm compared to other chondrocytes
in the histologic cartilage layer.
Within this grade, lack of matrix colouration by cationic
stains such as Safranin O or Toluidine Blue has been
deliberately omitted as a deﬁning feature. Under speciﬁed
conditions, these stains can be indicative of long-standing
cartilage matrix proteoglycan depletion. However, loss of
matrix staining can be attributed to transient endogenous
proteoglycan degradation28 or to histologic technique, such
as proteoglycan diffusion into ﬁxative during prolonged
storage in aqueous ﬁxatives (e.g., formalin). With an intact
superﬁcial zone, reversible loss of matrix staining can be
seen following acute traumatic injury. Permanent matrix
cationic staining loss is associated with extensive superﬁcial
zone cell death. Reversible matrix staining loss is charac-
teristic of the effects of proteolytic enzymes which may be
derived either from cartilage or from synovium28. Permanent
matrix staining loss is a result of cell death (necrosis and
apoptosis) coupled with inhibition of chondrocyte prolifera-
tion. In contrast, focal increased matrix staining in the
superﬁcial zone may be a feature of grade 1 OA.
Grade 2dGrade 2 OA is characterized by focal disconti-
nuity of the cartilage superﬁcial zone. Within this grade,
abrasion from shear forces leads to loss of small portions of
superﬁcial matrix parallel to the surface. The exfoliated
fragments may appear as matrix ‘‘ﬂakes’’ or ‘‘ﬁbrils’’ in
synovial ﬂuid. Formally, using material science nomencla-
ture, the loss of superﬁcial matrix fragments parallel to the
surface, ‘‘ﬂaking’’, is known as spallation (exfoliation). Within
this grade, one or morematrix cracksmay extend completely
through the superﬁcial zone (deep ﬁbrillation).
With the establishment of superﬁcial zone discontinuity,
matrix staining depletion within the upper one-third of
cartilage may be present. As a reaction, focal increased
staining about the chondrons, particularly in the upper mid
zone, may be seen. Chondrocytes within the mid zone may
show reactive changes demonstrated by clustering, as well
as focal expansion and/or loss of orientation of the
chondrons.
Fig. 2. OA cartilage pathology, OARSI grades 1e6, histologic features. (A & B): OA cartilage pathology: grades 1e6. Grade 1: surface intact.
The articular surface is uneven and can demonstrate superﬁcial ﬁbrillation. This may be accompanied by cell death or proliferation. The mid
zone and deep zone are unaffected. Grade 2: surface discontinuity. Focally ﬁbrillation extends through the superﬁcial zone to the superﬁcial
zoneemid zone portion Y. This may be accompanied by cell proliferation, increased or decreased matrix staining and/or cell death in mid
zone. Grade 3: vertical ﬁssures extending into mid zone. The matrix ﬁbrillation extends vertically downward into the mid zone. As the OA
Fig. 2. (continued)
becomes more extensive, the ﬁssures may branch and extend into the deep zone. Cell death and all proliferation may be observed most
prominently adjacent to ﬁssures. Grade 4: erosion. Cartilage matrix loss is observed which in earliest stage may be only delamination of
superﬁcial zone cartilage. More extensive erosion results illustrated in excavation, loss of matrix in ﬁssured domains. Grade 5: denudation.
The unmineralized hyaline cartilage is completely eroded. The articular surface is mineralized cartilage or bone. Microfracture through the
bone plate may result in reparative ﬁbrocartilage occupying gaps in the surface. Grade 6: deformation. The processes of microfracture, repair
and bone remodelling change the contour of the articular surface. At the earliest phase, illustrated, ﬁbrocartilage has grown along the level of
the previously eroded and denuded surface. Fibrocartilaginous articular surfaces, marginal and central osteophytes are processes associated
with more extensive articular contour deformation. (B) Safranin O stain, original magniﬁcation !5.
20 K. P. H. Pritzker et al.: Osteoarthritis cartilage histopathologyGrade 3dIn grade 3 OA, extension of matrix cracks into
the mid zone to form vertical ﬁssures (clefts) is observed.
As the process advances within this grade, the vertical
ﬁssures tend to extend and branch at angles from the
vertical. The matrix texture is likely to become more
heterogeneous, with adjacent domains of proteoglycan
depletion and increased staining observed. Polarized light
microscopy and/or Picro Sirius red staining after papain
digestion29 may demonstrate focal rarefaction and conden-
sation of collagen ﬁbres in the mid zone. Chondrocyte
death, complex chondrons (chondrons a feature of chon-
drocyte proliferation) containing multiple chondrocytes and
disoriented chondrocytes are likely to become more
prominent. This may be particularly evident in the chon-
drons immediately adjacent to the ﬁssures.
Grade 4dCartilage erosion is the principal incremental
feature of grade 4 OA. Two distinct processes can be
distinguished: delamination and excavation. Delamination
involves the loss of a superﬁcial zone fragment related to
the action of shear forces. Antecedent events include
circumferential extension of matrix cracks from the surface
through to the mid zone and tissue reaction, which
degrades cartilage matrix preferentially at the superﬁcial
zone/mid zone junction or within an oedematous upper mid
zone. For delamination to occur, the matrix subjacent to the
reactive domain must be relatively intact, such that a tissue
interface with different mechanical compliance (soft/hard)
develops. Crack propagation likely occurs ﬁrst by curvilinear
extension of the crack. Similar to the conditions beneath the
superﬁcial zone, at the outer vertical edge of the crack,
there is relatively slight reaction. As the crack expands, the
fragment becomes less mechanically stable, generating
more matrix reaction at the edge of the crack and at the
superﬁcial zone/mid zone interface. Further extension
dislodges the fragment resulting in delamination. Delami-
nation is recognized as the cartilage surface is relatively
smooth, yet the subjacent tissues have the appearance
(and reality) of mid zone cartilage organization.
Excavation represents cavity formation related to matrix
loss in a circumscribed cartilage volume. This is likely to
result from the extension and coalescence of branch
ﬁssures. Once again, this is not a purely mechanical
phenomenon. Necrosis and chondrocyte regeneration, as
well as matrix degradation (loss of matrix stain, collagen
ﬁbre rarefaction/collagen ﬁbre condensation) may be
observed in the matrix domains adjacent to the ﬁssures.
As the ﬁssures extend and coalesce, the fragment becomes
more unstable, increasing the reaction in adjacent, lateral
and deeper tissues. Finally, the fragment is set free by
mechanical forces as a microscopic ‘‘loose body’’. A variant
process, usually at the edges of the erosion contributing to
excavation, is mechanical dislodgement of deeply ﬁssured
cartilage matrix domains with release of matrix ﬁbrils into
the synovial ﬂuid. Presumably, several conditions including
pre-existing cartilage histologic structure, the rate of OA
progression in cartilage and the uniformity of the reaction
are determinants of the modes of excavation and the size of
the released matrix fragments. Cartilage matrix at a distance
from the ﬁssures may show increased collagen condensa-
tion and new collagen ﬁbre formation. The new collagen
ﬁbres may be thicker and more birefringent than pre-
existing ﬁbres. These collagen ﬁbres are usually type I
ﬁbres. These ﬁbres are produced by pre-existing chondro-
cytes that have undergone metaplasia to ﬁbrochondrocytes
or by chondrocytes that have migrated from reparative
cartilage present in the microfracture reparative tissue in the
articular plate4,27,30.Another process which may be present in grade 4 OA,
particularly in thick cartilage, is mid zone cyst formation
such as is found in chondromalacia patellae. Cyst formation
results from persistent oedema, with eventual loss of matrix.
This interior hollowing out process can be described as
cavitation. Extension of this process can lead to delamina-
tion of the superﬁcial and a portion of the upper zones.
On a smaller length scale, yet another process in which
there is loss of matrix, has been termed ‘‘lacunar re-
sorption’’16,17. This represents loss of ﬁbrillar matrix in
a perichondronal area, without collagen condensation or
further repair.
The area of ‘‘resorption’’ consists of ﬂuid containing
predominantly amorphous proteoglycan. This usually rep-
resents OA, which in the affected domains, has been
arrested in a state of incomplete repair.
Grade 5dGrade 5 OA is recognized by denudation,
complete erosion of hyaline cartilage to level of mineralized
cartilage and/or bone, whether or not the bone surface is
accompanied by ﬁbrocartilaginous repair. Typically, the
bone at the denuded surface appears denser than adjacent
bone. As well, the articular bone plate is thicker, not only at
the exposed area, but also beneath the adjacent cartilage.
While this bone is thicker (bone/marrow ratio), this bone
plate is usually less mineralized than deeper trabecular
bone31 and is more metabolically active32.
This results in microfractures through the bone plate with
ﬁbrocartilage repair. Thus, a portion of the denuded surface
may be ﬁbrocartilage. Under some circumstances, the
reparative ﬁbrocartilage is capable of growth and ﬁlling in of
part or the entire excavated hyaline cartilage volume.
Another common reaction is for appositional new bone to
form on the bone present at the denuded surface. Typically,
this bone can form a pattern of ridges and grooves aligned
in the direction of the joint motion. This pattern is still
considered within grade 5 OA.
More problematic is articular plate microfracture with
reparative ﬁbrocartilage from the fracture extending up-
ward into the deep layer of cartilage, while intact hyaline
cartilage or cartilage with lower osteoarthritic grades
remains above the ﬁbrocartilage. At the level of micro-
fracture, a simple discontinuity of the articular bony plate,
this is likely a common occurrence. This repair may
proceed to completion, restoring the bone plate without
further cartilage disruption. Accordingly, the presence of
ﬁbrocartilage in the deep zone, under this circumstance,
does not alter the OA grade. To repeat, grade 5 OA
requires denudation of hyaline cartilage from the affected
articular surface. In this grade, ﬁbrocartilage may be
present on the surface but no deformation of joint surface
geometry is acceptable.
Grade 6dGrade 6 OA is characterized by deformation,
change in the contour of the articular surface. This results
not only from articular plate fractures, but also from
increased metabolic activity of the articular bone plate, as
well as from activation of connective tissue at the lateral and,
sometimes, central cartilage/bone interfaces. The earliest
deformative change is growth of reparative ﬁbrocartilage
focally above the level of the previously eroded and
denuded articular surface. Deformation itself is a result of
articular bone plate microfracture and repair often frequently
repeated at adjacent sites. Articular plate fractures may lead
to successive, more lateral bone microfractures in which the
more central portion of the articular plate gradually slides
under the more marginal plate, displacing the marginal
portion outwards. Eventually, the submerged central hyaline
cartilage fragment becomes bound by cancellous bone
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connective tissue at the joint margin gives rise to ﬁbrocarti-
laginous proliferation and, subsequently, osseous meta-
plasia to form an osteophyte.
In this grading system for purposes of deﬁning grade,
osteophytes as a feature by themselves are excluded from
consideration.
Under some conditions, such as Diffuse Intervertebral
Skeletal Hyperostosis, connective tissue at the cartilage
bone joint margin becomes activated and osteophytes form
without cartilaginous features of OA33. These types of
osteophytes are excluded from consideration in this OA
grading system. Similarly, osteophytes may form at earlier
grades of OA where deformation is absent. As noted,
osteophyte formation, at ﬁrst, tends to affect the margins of
articular surfaces. Osteophytes adjacent to ligamentous
structures, such as ligament teres of the femoral head, are
considered topologically as marginal osteophytes.
Under some circumstances, osteophytes form more
centrally in the joint. These osteophytes arise from repa-
rative ﬁbrocartilage, which has ﬁlled space resulting from
cartilage excavation, a cartilage crack and microfracture.
These central osteophytes are usually associated with
articular surface deformation and are considered to be
a feature of grade 6 OA.
Advanced Grading MethodologydThe six OA grades
noted above can be used for most purposes. Advanced
grading methodology may be required for speciﬁc
research purposes, such as searching for additional
features with a speciﬁc histologic grade. For these
restricted purposes, it is possible to extend and subdivide
the grades for more detailed examination. The advancedsubgrade is indicated by adding 0.5 to the grade
(Table III).
Speciﬁc features within each OA grade indicate that the
lesion is more advanced. An advanced grade within the
primary grade is denoted by adding 0.5 to the primary grade.
Therefore, grade 1.0 would have intact chondrocytes,
whereas in grade 1.5, cell death by apoptosis or necrosis
would be seen. Similarly, in grade 2.0, the surface
discontinuity would consist of ﬁbrillation only, whereas in
grade 2.5, additionally, abrasion of the surface with loss of
a portion of the superﬁcial cartilage zone would be seen. In
grade 3, penetration into the mid zone is seen by the
presence of simple ﬁssures or clefts. In grade 3.5, extension
of ﬁssures to become branched or complex ﬁssures is noted.
In grade 4, where the key feature is erosion, grade 4.0
represents superﬁcial zone delamination (loss of the
superﬁcial zone only), whereas grade 4.5 shows excavation
into the mid zone. In grade 5, where denudation is a key
feature, grade 5.0 represents presence of a bone surface
which consists of intact calciﬁed cartilage or sclerotic bone,
whereas in grade 5.5 at the denuded surface, reparative
ﬁbrocartilaginous tissue or new bone formation is observed.
In grade 6, grade 6.0, deformation of the joint geometry at the
joint margins is seen, whereas in grade 6.5, the extent of
remodelling is such that both the joint margins and force-
bearing areas show deformation changes.
OA stage. Initially, OA progression involves focal involve-
ment of cartilage usually subjacent to the surface affected
most by mechanical force. Other portions of the articular
cartilage and other cartilages in the joint remain structurally
intact. With progression, osteoarthritic changes areTable III
OA cartilage histopathology grade assessmentdadvanced grading methodology
Grade (key feature) Subgrade (optional) Associated criteria (tissue reaction)
Grade 0: surface intact,
cartilage intact
No subgrade Intact, uninvolved cartilage
Grade 1: surface intact 1.0 Cells intact Matrix: superﬁcial zone intact,
edema and/or ﬁbrillation1.5 Cell death
Cells: proliferation (clusters), hypertrophy
Reaction must be more than
superﬁcial ﬁbrillation only
Grade 2: surface
discontinuity
2.0 Fibrillation through superﬁcial zone As above
2.5 Surface abrasion with matrix loss
within superﬁcial zone
CDiscontinuity at superﬁcial zone
GCationic stain matrix depletion (Safranin
O or Toluidine Blue) upper 1/3 of cartilage
(mid zone)
GDisorientation of chondron columns
Grade 3: vertical
ﬁssures
3.0 Simple ﬁssures As above
3.5 Branched/complex ﬁssures GCationic stain depletion (Safranin O or
Toluidine Blue) into lower 2/3 of cartilage
(deep zone)
GNew collagen formation (polarized light
microscopy, Picro Sirius Red stain)
Grade 4: erosion 4.0 Superﬁcial zone delamination Cartilage matrix loss, cyst formation within
cartilage matrix4.5 Mid zone excavation
Grade 5: denudation 5.0 Bone surface intact Surface is sclerotic bone or reparative tissue
including ﬁbrocartilage5.5 Reparative tissue surface present
Grade 6: deformation 6.0 Joint margin osteophytes Bone remodelling. Deformation of articular
surface contour (more than osteophyte
formation only)
6.5 Joint margin and central osteophytes Includes: microfracture and repair
I. GradeZ depth progression into cartilage.
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advanced OA, the entire joint surface is involved.
OA stage represents the proportion of articular surface
that is involved with OA compared to the total surface
length, irrespective of the subjacent OA grade or whether
the OA involvement is discontinuous (multiple lesions). As
the grade may be variable, typically low at the lesion edge
and rising higher at the centre, this method biases the
histopathology assessment towards more advanced arthri-
tis when an OA score is used.
Recommended OA staging method. Four OA stages are
deﬁned, depending on the horizontal extent of the involved
cartilage surface irrespective of underlying OA grade. As
seen in the microscopic section, stage 1 represents less
than 10% involvement. Stage 2 represents 10e!25%
involvement. Stage 3 represents 25e50% involvement.
Stage 4 represents more than 50% involvement (Table IV).
Each successive stage represents an exponential rather
than linear progression from the previous stage. While
arbitrary, this methodology appears more sensitive to early
or mild OA than using a linear scale. Most OA lesions are
continuous, although the grade within the lesion might vary.
For discontinuous lesions, the stage is considered as the
sum of the total surface length involved with OA to the total
surface length.
Alternative staging methods. Staging by surface length
is suitable for most applications. For specialized applica-
tions including different types of microscopy, OA stage can
also be assessed as proportion of area or volume. These
assessments can be denoted as follows: stage (length)
(Sl); stage (area) (Sa) and stage (volume) (Sv). For staging
according to length criteria, microscopic visualization is
adequate. For staging according to area or volume
assessments, morphometric techniques are recommen-
ded.
Morphometric assessment of grade and stage. For
more specialized research applications, if desired, both
grading and staging technology can be extended to
incorporate morphometric technology. Stage can be
assessed as percent of joint surface. Typically, these
measurements are time consuming and require high
expertise to deﬁne the borders of cartilage domains.
Therefore, these methods should be reserved for those
studies where qualitative methods are insufﬁciently precise
to distinguish different OA groups.
OA score. As stated previously, OA cartilage score
represents a combined assessment, based on both the
severity (grade) and extent (stage) of OA in the articular
cartilage. An OA cartilage score can be determined using
either qualitative, semi-quantitative or quantitative methods.
Table IV
OA cartilage histopathologydstage assessment
Stage % Involvement
(surface, area,
volume)
Stage 0 No OA activity seen
Stage 1 !10%
Stage 2 10e25%
Stage 3 25e50%
Stage 4 O50%
StageZ extent of joint involvement.In considering scoring methodology, the method selected
should be as simple as that required to obtain the
information needed to separate OA from controls or to
compare one OA set with another.
To compare an OA test group to controls, qualitative or
semi-quantitative methods are usually sufﬁcient. To com-
pare the extent of OA between cartilage domains within
a model, quantitative methods are recommended as a ﬁrst
choice.
Recommended OA score method. The recommended
score is an index of combined grade and stage. The simple
formula: scoreZ grade! stage is recommended. This
method produces an OA score with a range of 0e24 based
on the most advanced grade and most extensive stage
present (Table V). This method provides equal ordinal
number weight to severity (grade) and to extent (stage).
This method continues to bias OA assessment towards the
most advanced disease observed.
Because this scoring method is dependent on multiples
of primes, there are ‘‘voids’’ or gaps in the scoring system,
representing prime numbers or multiples of primes above
the primes used to assess grade for an individual
specimen. Because of this mathematical anomaly for
individual scores, this simple scoring system omits the
OA scores 7, 11, 13, 14, 17, 21, 22 and 23. From Table V,
it can be seen that this loss of linearity mostly involves OA
at high grade and extensive stage. However, depending
on the number of samples involved and the extent of OA,
scores within these numbers may be seen in group scores
(which are averages of individual scores). In the absence
of an absolute standard for OA progression, this mathe-
matical anomaly is not relevant. If required, this difﬁculty
can be circumvented by assessing score based on
measuring stage as the percentage of cartilage surface
involved with OA.
Alternative OA score methods. (1) Qualitative Score,
Simple Method. This indicates the most advanced OA
grade/stage observed in the section, e.g., grade 2, stage 3.
This method has the advantage of providing one grade and
one stage, which is indicative of the most advanced grade
and most advanced stage present. With this method, OA
severity is distinguished from OA extent. (2) Qualitative
Score, Complex Method. This measures the most ad-
vanced stage for each grade, e.g., G1S4, G2S3, G3S2.
This method may give a more accurate portrayal of how
much OA is in the joint. However, this requires much more
assessment time.
The alternative methods may be useful to indicate the
amount of OA in special situations, for example, individual
clinical samples. With these methods, comparison between
patient samples is more cumbersome and must be restricted
Table V
OA scoredsemi-quantitative method
Grade Stage
S1 S2 S3 S4
G1 1 2 3 4
G2 2 4 6 8
G3 3 6 9 12
G4 4 8 12 16
G5 5 10 15 20
G6 6 12 18 24
ScoreZ grade! stage.
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OA cartilage histopathology grade assessmentdcomparison of methods
Feature OARSI system HHGS7
1. Principle Assumes histologic features present Characteristic OA histologic features,
presence and amountGradingZ vertical depth
StagingZ surface, area or volume extent
2. Quantiﬁcation Grading: score is progressive with depth Speciﬁc feature or scoreZ combination
of features
Staging: score is progressive with length,
area or volume involved
Total scoreZ sum of feature scores
Total score: qualitative and quantitative options
3. Macroscopic assessment correlation
(gross pathology)
Direct Indirect
4. Arthroscopy correlation Direct Indirect
5. Imaging correlation Direct Indirect
6. Expandable
6.1. Subdivide grade if required Yes No
6.2. Can include new features in grade Yes No
6.3. Morphometry for staging Yes No
7. Score range 0e24 0e14
8. Identify early OA Expanded proportional score 0e12 of 24 Limited: score 0e4 of 14
9. Validity Requires further validation Not validto counting the number of samples which are assigned to
each score category.
Discussion
A comparison of the OARSI Scoring System proposed
above and the HHGS is shown in Table VI. The HHGS
assigns grades to histologic features characteristic of OA,
independent of the location or extent. The HHGS develops
the combined score based on qualitative assignment of
numbers as speciﬁc OA histologic features. At least one
major feature, matrix cationic stain depletion may be
physiologically transient under some conditions and,
technically, is highly subject to the vagaries of histological
preparation. Further, the HHGS cannot distinguish low
grade OA present over a small portion of the surface from
more extensive OA of the same grade. In contrast, the
OARSI system assumes prior recognition that osteoarthritic
histologic features are present. Where deﬁned OA histology
features are present, grade is assigned to the vertical depth
within cartilage (reﬂecting the biologic aggressiveness of
the lesion) and stage to the horizontal, two-dimensional or
three-dimensional extent (surface or volume), irrespective
of particular OA features. As depth and horizontal extent are
simpler features to assess than differences amongst
particular OA features, it is likely that the OARSI system
can be applied more consistently by less experienced
observers than the HHGS.
The simplest application of the OARSI system can be
assessed using grade only (six grades) or stage only (four
stages). Use of a cartilage OA score permits more
complete assessment of the cartilage histopathology.
The simple semi-quantitative score method, scoreZ gra-
de! stage, even with its ordinal gaps of potential scores
for individual compartment assessment is the most
practical for most studies. As noted above, the mathemat-
ical anomaly disappears when OA stage is assessed
morphometrically.
The OARSI system also permits direct correlation of OA
stage with macroscopic assessment (gross pathology),
arthroscopy and imaging (X-rays, magnetic resonance
imaging) or other techniques. The present system is alsoexpandable in that the grade can be subdivided. New
features can be included in the grade as they become
validated. The OARSI system is also very amenable for
morphometry.
A particular feature of the OARSI system is its capacity
to identify differences within early or mild OA (grades 1e3).
By deﬁning earlier or mild OA features more precisely,
a proportionally expanded score for early or mild OA is
available. It is anticipated that the OARSI system will result
in less variation amongst observers and proportionally
a wider range of scores in early or mild OA than the HHGS
system.
NEXT STEPS
At this early stage, the OARSI criteria for OA histopa-
thology assessment appear superior to previous methods.
Preliminary assessment amongst multiple observers indi-
cates that the OARSI osteoarthritis cartilage histopathology
scoring system is reproducible and useful34e36. Much work
remains to develop standards for pathologic assessment,
sample preparation and staining, as well as, where needed,
exclusionary criteria for other clinical forms of arthritis.
Further, more extensive validation is required in both
clinical and experimental arthritis before this methodology
can truly be accepted as the standard with widespread
consensus. While further assessment will be required, the
OARSI Cartilage Histopathology Grading/Staging System
is an instrument that does show considerable promise to
become a standard tool for OA cartilage histopathology
assessment.
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OA CARTILAGE: STRUCTURAL FEATURES
This glossary contains terms used in this article, together
with synonyms and comments. References are to use of the
terms in earlier publications, but may not be the ﬁrst
application of each term.
The terms are classiﬁed as follows:
A.1 Articular cartilage cells (chondrocytes) and the
chondronA.2 Articular cartilage matrix and bone: structures (matrix
compartments)
A.3 OA: articular lesions
A.3.1 Cartilage matrix texture/composition
A.3.2 Cartilage matrix disruption
A.3.3 Cartilage matrix loss
A.3.4 Bone featuresA.1
Articular cartilage cells (chondrocytes) and the chondron
Preferred term Deﬁnition Synonym Reference no.
Chondrocyte Cartilage cell within cartilage matrix  Chondrocyte (37)
 Cell
Chondrocyte hypertrophy Increase in cell size (increased cytoplasm)
Chondrocyte necrosis Cell death (usually increased membrane
permeability)
 Cell death (38)
 Empty lacuna
Chondrocyte apoptosis Programmed (controlled) cell death  Pyknotic cell (38,39)
 Fragmented nuclei
Chondrocyte atrophy Decrease in cell size (decreased cytoplasm)
Chondrocyte density Chondrocytes/unit area cartilage  Chondrocyte density (40)
Increased chondrocyte
density
Increased chondrocytes/unit area cartilage  Hypercellularity
 Increased cellularity
Decreased chondrocyte
density
Decreased chondrocytes/unit area cartilage  Hypocellularity (7)
Chondron Cartilage cell including pericellular matrix  Cell and pericellular matrix (37)
The chondron is a functional structure.  Chondron (4,41e45)
 Lacuna (46e49)
Chondron hypertrophy Increase in chondron size  Chondrocyte hypertrophy
Chondron atrophy Decrease in chondron size
Complex chondron Multiple chondrocytes sharing pericellular
matrix within a chondron
 Brood capsule (50)
 Clone (7,46,51)
 Synthetic clone (52)
 Degenerative clone (52)
 Cluster (46,50,53)
 Clustered chondron clumps (37,51)
 Focal cell proliferation (4,51)
 Chondrocyte clusters (4,51)
 Hypercellularity
 Diffuse hypercellularity
 Cell aggregates (54)
Chondron density Chondrons/unit area cartilage  Chondron density (40)
Chondrocytes/chondron  Chondrocytes/chondron cells/clusters
A.2
Articular cartilage matrix and bone: structures (matrix compartments)
Preferred term Deﬁnition Synonym Reference no.
Cartilage matrix
Zone Volume of cartilage parallel to joint surface
with similar composition and architecture.
 Lamina
 Domain
 Layer
(51,55,56)
Superﬁcial zone Cartilage zone at joint surface. Collagen
ﬁbres are aligned parallel to surface.
Chondrocytes, elongated and ﬂattened, are
aligned parallel to collagen ﬁbres and to
joint surface.
 Lamina splendens
 Horizontal zone
 Tangential zone
 Zone 1
 Superﬁcial layer
(56e58)
Mid zone Zone subjacent to superﬁcial zone. Collagen
ﬁbres are aligned intermediately between
superﬁcial and deep zone alignments.
Chondrocytes present in groups (chondrons)
aligned parallel to collagen ﬁbres.
 Transitional zone
 Intermediate zone
 Zone 2
(56,57)
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(continued )
Preferred term Deﬁnition Synonym Reference no.
Deep zone Zone subjacent to mid zone and above calciﬁed cartilage.
Collagen ﬁbres are aligned predominantly perpendicular
to joint surface. Chondrocytes within chondrons are aligned
parallel to collagen ﬁbres and perpendicular to joint surface.
 Radial zone
 Zone 3
(56,57)
Tidemark Zone of increased calciﬁcation
at border of uncalciﬁed and
calciﬁed cartilage.
 Calciﬁcation front
 Ligne bordant (line of
increased basophilic stain)
(56,57)
Calciﬁed cartilage Calciﬁed cartilage matrix. Collagen ﬁbres and
chondrocytes are aligned similar to deep zone cartilage.
 Zone 4
 Zone calciﬁe´
(55,57,59)
Cement line Zone of increased calciﬁcation between calciﬁed
cartilage and bone.
 Cement line
Line of increased basophilic stain.
Bone structures
Articular bone plate Bone subjacent to articular cartilage. Collagen
ﬁbres aligned predominantly parallel to articular surface.
 Os sous-chondral (56)
Subchondral trabecular bone Bone subjacent to articular bone plate. Collagen
ﬁbres are aligned predominantly perpendicular to
articular surface.
Chondron capsule Domain of increased collagen including collagen VI
surrounding chondron. Capsule is arranged spherically
or in a vertical ovoid around the chondron.
(41)
Chondron perilacunar matrix Extracellular matrix within chondron  Lacunar matrix (41,43,45)
Territorial matrix Extracellular matrix surrounding chondron.
Usually, this matrix shows more intense cationic
stain than the interterritorial matrix. Staining
is aligned circumferentially around chondron.
(45)
Interterritorial matrix Extracellular matrix between domains of territorial matrix.
Cationic staining is amorphous, not aligned to chondrons.
(45)
A.3.1
Cartilage matrix texture/composition
Preferred term Deﬁnition Synonym Reference no.
Matrix domain Circumscribed area or volume of cartilage matrix with
similar matrix texture/composition
 Area, volume
Matrix oedema Matrix oedema. Increase in matrix thickness  Matrix oedema
 Oedema
 Matrix swelling
 Matrix hypertrophy
 Chondromalacia
(4)
Increased matrix
proteoglycan
Enhanced cationic staining (Safranin O,
Toluidine Blue)
 Hyperchromasia
 Metachromasia (Toluidine Blue)
 Increased charge density
Decreased matrix
proteoglycan
Decrease or absence of matrix cationic
staining (Safranin O, Toluidine Blue)
 Staining loss
 Decreased charge density
 Glycosaminoglycan depletion
 Matrix proteoglycan depletion
Matrix atrophy Decrease in matrix thickness without disruption
of surface layer
Collagen condensation [ collagen ﬁbre density. No alteration in collagen ﬁbre
size or orientation. Decreased space between ﬁbres
 Fibrosis
 ‘‘Matrix streaks’’
(60)
Collagen rarefaction Y collagen ﬁbre density. No alteration in
collagen ﬁbre size. Increased space
between collagen ﬁbres
 Oedema
Increased collagen
formation
[ collagen ﬁbres with changes in ﬁbre thickness,
length (usually longer, thicker, increased heterogeneity)
 Fibrosis
 Amianthoid ﬁbres
(61)
Collagen resorption Y or absent collagen ﬁbres. Adjacent ﬁbres, no changes
A.3 OA: articular lesions
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Cartilage matrix disruption
Preferred term Deﬁnition Synonym Reference no.
Fibrillation Vertical cracks, irregularities or discontinuities
of cartilage matrix conﬁned to superﬁcial zone
 Fibrillation (37,46)
 Superﬁcial ﬁbrillation (4)
 Mild ﬁbrillation (46)
 Abrasion (37)
 Cleft (4,46,62)
 Crack (37)
 Discontinuity (37)
 Minimal ﬁbrillation (46,53)
 Flaking, fraying, irregularity (7,37)
 Split (37)
Superﬁcial ﬁbrillation Matrix discontinuity (crack) into the superﬁcial zone  Abrasion
 Crack
Deep ﬁbrillation Matrix discontinuity through the superﬁcial zone  Crack
 Fissure
Fissure Vertical (60e90( to articular surface) matrix separation
extending into mid and deep cartilage
 Fissure (37)
 Simple ﬁssure
 Branched ﬁssure
 Cleft (4,7,37,46,51,62,63)
 Crack (51)
 Crevice
 Deep ﬁbrillation (4,46,53,62)
 Late ﬁbrillation (4,50)
 Overt ﬁbrillation (64,65)
 Ravine (64,65)
 Split (63)
Simple ﬁssure Unbranched ﬁssure
Branched ﬁssure Fissure with one or more branch extensions
Complex ﬁssure Fissure with secondary branches propagating inward
towards original ﬁssure as well as outward
Split Horizontal (0e60( to cartilage surface) matrix separation
at junction of superﬁcial and mid zone or to within mid
or deep cartilage
(63,66)
A.3.3
Cartilage matrix loss
Preferred term Deﬁnition Synonym Reference no.
Perichondronal
matrix disruption
Resorption of pericellular matrix adjacent to chondron with
replacement by loose ﬁbrous tissue G ﬁbrocytes
 Lacunar resorption (16,52)
 Cellular resorption (63)
 Pericellular lacunar wall (49,56)
 Pericellular lacunar lesion (48)
 Chondron enlargement
Abrasion Focal loss of surface portion of superﬁcial zone leaving rough
surface
Delamination Focal superﬁcial zone matrix loss extending to mid zone  Flaking (67)
 Spallation
Spallation Mechanical activity which results in loss of matrix fragment
from cartilage
 Exfoliation
Excavation Activity that results in loss of cartilage fragment deep to
superﬁcial layer
Usually, intact cartilage is present laterally
Erosion Loss of articular cartilage tissue including superﬁcial and
at least portions of deeper cartilage layers
 Ulceration (68)
Cavitation Formation of a cyst or ﬂuid-ﬁlled space within cartilage  Cyst (69)
This process, representing extreme oedema of mid zone, may
be seen in chondromalacia
Denudation Matrix loss extending to calciﬁed cartilage interface  Ulceration (68)
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Bone features
Preferred term Deﬁnition Synonym Reference no.
Tidemark Thin layer (line) detected by increased basophilic staining
demarcating transition from uncalciﬁed to calciﬁed cartilage
Tidemark ligne bordant (56,70)
Tidemark
penetration
Extension of subchondral blood vessel through the tidemark Subchondral bone resorption
Subchondral bone resorption pit (45)
Microcracks (4,44)
Vascular channels (43)
Vascular penetration
Tidemark
advancement
Extension of calciﬁed zone with replication of tidemark at new
calciﬁed/uncalciﬁed cartilage boundary
Tidemark
duplication
Two or more tidemarks indicative of multiple episodes of tidemark
advancement
Articular plate
fracture
Discontinuity through subchondral bone plate
Deformation Distortion of contour of articular surface secondary to bone
remodelling
Eburnation Smooth shiny ‘‘burnished’’ articular surface indicative of exposed
bone at articular surface
Ulceration (68)
Corrugated bone
articular surface
Eburnated bone surface with ridges and grooves aligned in plane
of joint motion
Osteophyte Growth of bone structure usually from joint margin (peripheral
osteophyte). Osteophytes can also grow from subchondral bone
into cartilage during repair of microfracture (central osteophyte)
(50,51)Appendix B. OARSI cartilage pathology
Histological preparations for OA pathology assessment
1. OA lesion registration and block selection: To locate
the block with reference to the osteoarthritic lesion,
a photograph and drawing of the articular surface is
made including the lesion. A line is drawn on the
document at plane and location of histologic block
sample, usually through the maximal cross-section of
the lesion in the plane of section.
2. Specimen X-ray: To record the original dimensions, as
well as determine bone architecture and density. The
sample is X-rayed using a ﬁne focus equipment in an
enclosed X-ray system.
3. Fixation and decalcification: The sample which in-
cludes articular cartilage and subjacent bone is ﬁxed in
50 volumes of 10% neutral buffered formalin for
a period of 72 h. All samples undergo macroscopic
lesion identiﬁcation and subsequent marking on the
sample. The specimen is decalciﬁed in 10% formic
acid or equivalent ethylene diamine tetra-acetic acid
solution in a container placed on an orbital shaker at
150 revolutions per minute. The decalcifying solution is
changed everyday until decalciﬁcation is achieved.
Completion of decalciﬁcation is monitored by perform-
ing chemical endpoint assay. Once decalciﬁcation is
complete, the samples are rinsed thoroughly in
distilled water to achieve neutral pH.
4. Block processing, embedding and cutting: The block is
dehydrated in graded alcohols, cleared in xylene and
embedded in Paraplast using an automated tissue
processor using a schedule of 58 h. The samples are
embedded with the marked lesion area closest to the
surface that has the undergone microtomy.
5. Microtomy and staining: The blocks aligned in the
same plane are cut at 5 mm and subsequently stained
with Safranin O.
To ensure consistency of staining, a control section of
a block with known staining characteristics is stainedwith each sample. In experimental studies, both
control and test slides are stained in each batch.
Duplicate slides of selected samples are stained. If
there is substantial variation in staining intensity,
staining processes and solutions are reviewed. A
common cause of sample variation is misalignment of
microtome. This can result in a differing thickness
across slide resulting in different staining densities.
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